- Number of people
- 154 (60.39% female)
- People with ≥2 records
- 1.30%
- Median duration from first to last measurement
- — years
Acarus siro IgE Ab [Units/volume] in Serum
Coding
Definition
- OMOP Concept ID
- 3015665— open in OHDSI Athena.
- Part of collection
- Acarus siro IgE with 0 other OMOP concept — open in OHDSI Athena.
OMOP mapping QC
| OMOP concept ID | Test name | Measurement unit (harmonized unit) | N people | N records | Missing measurement value | Harmonized value distribution |
Test outcome
NA
N
A
AA
L
LL
H
HH
|
|---|---|---|---|---|---|---|---|
| 3015665 | s-asiroe | u/ml (u/ml) | 88 | 89 | 11.24% |
|
|
| 3015665 | s-asiroe | — (—) | 67 | 67 | 100.00% | Distribution not available |
Cohort
- Number of people
- 154 (60.39% female)
Year of birth distribution
Age at first measurement
Age at last measurement
Age at start of registry
Duration from first to last measurement
Statistics
- People with ≥2 records
- 1.30%
- Median number of measurements per person
- 1.0
- Median duration from first to last measurement
- —
Number of measurements over the years
Number of measurements per person
Distribution of lab values
Reference range
N people
N records
—
84
84
alle0.35/kaikki
19
19
<0.35/KAIKKI
18
18
-ALLE0.35
18
19
0-0.35/KAIKKI
11
11
<0.35
5
5
Value range per person
LabWAS
Endpoint
People with measurements
Mean N measurements
Mean measured value
Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
79
20
23.56
74.98
1.0
1.0
0.27
0.13
u/ml
—
44
8
81
70
10.37
69.27
1.0
1.0
0.27
0.35
u/ml
0.17
46
31
35
31
11.31
33.53
1.0
1.0
0.63
0.11
u/ml
0.64
15
15
48
72
3.34
10.84
1.0
1.0
0.22
0.26
u/ml
0.07
26
33
35
45
3.94
9.86
1.0
1.0
0.16
0.45
u/ml
0.30
20
14
22
57
3.78
7.42
1.0
1.0
0.33
0.19
u/ml
0.25
11
26
21
62
3.35
6.01
1.0
1.0
0.06
0.21
u/ml
1.05
13
30
17
33
2.58
2.73
1.0
1.1
0.12
0.08
u/ml
—
8
12
26
99
1.97
2.56
1.0
1.0
0.60
0.24
u/ml
0.44
17
48
33
119
1.58
1.57
1.0
1.0
0.23
0.32
u/ml
0.19
18
60
17
45
1.89
1.46
1.0
1.0
0.14
0.45
u/ml
—
7
14
19
70
1.72
1.31
1.0
1.0
0.44
0.36
u/ml
0.06
11
35
16
45
1.82
1.26
1.0
1.0
0.89
0.45
u/ml
—
6
14
30
113
1.50
1.21
1.0
1.0
0.23
0.32
u/ml
0.19
18
59
29
100
1.51
1.18
1.0
1.0
0.12
0.37
u/ml
0.85
12
55
0
29
0.00
1.17
0.0
1.0
—
0.03
—
0
19
0
33
0.00
1.15
0.0
1.0
—
0.12
—
0
16
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
0
35
0.00
1.15
0.0
1.0
—
0.08
—
0
15
15
45
1.77
1.12
1.0
1.0
0.30
0.45
u/ml
—
10
14
18
55
1.64
1.04
1.0
1.0
0.19
0.21
u/ml
—
8
27
24
108
1.45
0.89
1.0
1.0
0.37
0.26
u/ml
0.13
14
56
17
69
1.55
0.85
1.0
1.0
0.06
0.27
u/ml
—
9
41
21
104
1.37
0.62
1.0
1.0
0.32
0.28
u/ml
—
8
53
12
127
0.68
0.62
1.0
1.0
0.86
0.26
u/ml
—
6
68
19
129
0.76
0.49
1.0
1.0
0.16
0.24
u/ml
0.29
11
65
14
131
0.75
0.43
1.0
1.0
0.93
0.22
u/ml
—
9
65
16
60
1.34
0.42
1.0
1.0
0.12
0.12
u/ml
—
8
31
26
106
1.24
0.42
1.0
1.0
0.14
0.38
u/ml
0.88
11
56
0
15
0.00
0.41
0.0
1.0
—
0.06
—
0
7
0
18
0.00
0.40
0.0
1.0
—
0.09
—
0
6
14
105
1.33
0.40
1.0
1.0
0.04
0.24
u/ml
—
9
55
24
110
1.22
0.34
1.0
1.0
0.05
0.38
u/ml
—
10
57
19
129
0.84
0.26
1.0
1.0
0.64
0.24
u/ml
0.37
12
65
13
100
0.81
0.24
1.0
1.0
1.04
0.10
u/ml
—
8
46
13
100
0.81
0.24
1.0
1.0
1.04
0.10
u/ml
—
8
46
0
11
0.00
0.21
0.0
1.0
—
0.32
—
0
5
0
12
0.00
0.21
0.0
1.0
—
0.13
—
0
5
0
14
0.00
0.20
0.0
1.0
—
0.04
—
0
6
0
14
0.00
0.20
0.0
1.0
—
0.12
—
0
6
0
14
0.00
0.20
0.0
1.0
—
0.02
—
0
5
0
14
0.00
0.20
0.0
1.0
—
0.03
—
0
6
14
114
1.18
0.17
1.0
1.0
0.25
0.26
u/ml
—
5
61
16
100
0.88
0.15
1.0
1.0
0.11
0.33
u/ml
—
9
49
12
94
0.87
0.12
1.0
1.0
0.06
0.19
u/ml
—
6
48
12
93
0.87
0.11
1.0
1.0
0.65
0.24
u/ml
—
6
46
22
102
1.08
0.08
1.0
1.0
0.36
0.19
u/ml
0.37
13
48
16
123
0.93
0.05
1.0
1.0
0.31
0.27
u/ml
—
10
61
13
75
1.09
0.05
1.0
1.0
0.03
0.24
u/ml
—
7
38
18
135
0.95
0.03
1.0
1.0
0.24
0.30
u/ml
0.10
12
67
11
101
1.07
0.02
1.0
1.0
1.45
0.09
u/ml
—
5
51
21
131
0.99
0.00
1.0
1.0
0.08
0.34
u/ml
1.24
12
66
10
59
1.00
0.00
1.0
1.0
0.08
0.08
u/ml
—
5
30
16
104
1.02
0.00
1.0
1.0
0.13
0.18
u/ml
—
9
52